An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.

Name: An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.
Published: 2016
License: Public Domain

Yonsei University · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

recurrent or metastatic squamous cell carcinoma of head and neck, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.

Related documents